Finance

Lists
Why is KYTX down ၇.၀၉%?
Dive Deeper
KYTX:NASDAQ
Kyverna Therapeutics Inc
၅.၇၇ US$
-၇.၀၉%
(-၀.၄၄) 1D
၅.၈၂ US$
+၀.၈၇% (+၀.၀၅၀)
After hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYTX...
Open
၆.၁၇ US$
High
၆.၁၇ US$
Low
၅.၇၆ US$
Mkt. cap
၃၅.၆၈ ကုဋေ
Avg. vol.
၉.၁၈ သိန်း
Volume
၁.၂၄ သန်း
52-wk high
၁၃.၆၇ US$
52-wk low
၅.၇၆ US$
EPS
-၂.၉၄ US$
Shares outstanding
၆.၁၈ ကုဋေ
No. of employees
၁၄၉
Open
၆.၁၇ US$
High
၆.၁၇ US$
Low
၅.၇၆ US$
Mkt. cap
၃၅.၆၈ ကုဋေ
Avg. vol.
၉.၁၈ သိန်း
Volume
၁.၂၄ သန်း
52-wk high
၁၃.၆၇ US$
52-wk low
၅.၇၆ US$
EPS
-၂.၉၄ US$
Shares outstanding
၆.၁၈ ကုဋေ
No. of employees
၁၄၉
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
Range Capital Acquisition Corp II (NASDAQ:RNGT) Sees Significant Decline in Short Interest
RealMoney Pro
RealMoney Pro
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
The Either/Or Market Remains Undefeated
Barron's
Barron's
·
ပြီးခဲ့သည့် ၆ နာရီ
The AI Trade Led the Bull Market—but Don’t Bail on the Big Winners Just Yet
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow Jones Futures: Stock Market Holds Up As Meta, AMD Lead Buys; ASML, CPI Inflation Due
About Kyverna Therapeutics Inc
CEO-
Employees၁၄၉
Founded၂၀၁၈
HeadquartersEmeryville, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to KYTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KYTX in the last 3 months.
Highest
Current ၅.၇၇ US$
၃၃.၀၀ US$ (+၄၇၁.၉၂%)
Average
၃၀.၃၃ US$ (+၄၂၅.၆၅%)
Lowest
၂၅.၀၀ US$ (+၃၃၃.၂၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
၂၅.၀၀ US$
+၃၃၃.၃%
09/25/2026
Derek Archila
Wells Fargo
Buy
Reiterated
၃၃.၀၀ US$
+၄၇၁.၉%
09/25/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
09/24/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
၃၃.၀၀ US$
+၄၇၁.၉%
08/12/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/12/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
၂၉.၀၀ US$
+၄၀၂.၆%
05/13/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
၃၀.၀၀ US$
+၄၁၉.၉%
03/30/2026
Last report
၂၀၂၆ ဩ ၁၁
Fiscal period
Q2 2026
-၀.၆၃ US$ / -၀.၆၈ US$
+၇.၂၈%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၃.၀၅ ကုဋေ
-၁၀.၃၇ ကုဋေ
၃.၀၁ ကုဋေ
-
Cost of revenue
၃.၀၅ ကုဋေ
-၁၀.၃၇ ကုဋေ
၃.၀၁ ကုဋေ
-
Research and development expenses
-
၁၃.၃၇ ကုဋေ
-
၂.၄၈ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၂၇ သန်း
၉.၂၇ သန်း
၁.၁၃ ကုဋေ
၁.၄၈ ကုဋေ
Operating expense
၈.၂၇ သန်း
၁၄.၃၀ ကုဋေ
၁.၁၃ ကုဋေ
၃.၉၆ ကုဋေ
Total operating expenses
၃.၈၇ ကုဋေ
၃.၉၃ ကုဋေ
၄.၁၄ ကုဋေ
၃.၉၆ ကုဋေ
Operating income
-၃.၈၇ ကုဋေ
-၃.၉၃ ကုဋေ
-၄.၁၄ ကုဋေ
-၃.၉၆ ကုဋေ
Other non operating income
-၅.၃၀ သောင်း
၁.၇၀ သောင်း
-၂.၁၀ သောင်း
-၁.၈၀ သောင်း
EBT including unusual items
-၃.၆၈ ကုဋေ
-၃.၇၈ ကုဋေ
-၃.၉၇ ကုဋေ
-၃.၈၃ ကုဋေ
EBT excluding unusual items
-၃.၆၈ ကုဋေ
-၃.၇၈ ကုဋေ
-၃.၉၇ ကုဋေ
-၃.၈၃ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၃.၆၈ ကုဋေ
-၃.၇၈ ကုဋေ
-၃.၉၇ ကုဋေ
-၃.၈၃ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၈၅
-၀.၈၀
-၀.၆၆
-၀.၆၃
Interest and investment income
၂.၀၀ သန်း
၁.၉၀ သန်း
၂.၃၃ သန်း
၁.၉၃ သန်း
Interest expense
-၇.၀၀ ထောင်
-၄.၄၄ သိန်း
-၆.၆၇ သိန်း
-၆.၇၄ သိန်း
Net interest expenses
၁.၉၉ သန်း
၁.၄၆ သန်း
၁.၆၆ သန်း
၁.၂၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၃.၇၈ ကုဋေ
-၃.၈၉ ကုဋေ
-၄.၁၀ ကုဋေ
-၃.၉၁ ကုဋေ
Gain or loss from assets sale
၄.၀၀ သောင်း
၂.၀၀ သောင်း
-
-၄.၇၀ သောင်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ